Ribavirin is effective against drug-resistant H7N9 influenza virus infections
Open Access
- 18 July 2016
- journal article
- letter
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 7 (8) , 611-614
- https://doi.org/10.1007/s13238-016-0287-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Epidemiology, Evolution, and Recent Outbreaks of Avian Influenza Virus in ChinaJournal of Virology, 2015
- Dissemination, divergence and establishment of H7N9 influenza viruses in ChinaNature, 2015
- The R292K Mutation That Confers Resistance to Neuraminidase Inhibitors Leads to Competitive Fitness Loss of A/Shanghai/1/2013 (H7N9) Influenza Virus in FerretsThe Journal of Infectious Diseases, 2014
- Influenza and the Live Poultry TradeScience, 2014
- Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in ChinaNew England Journal of Medicine, 2014
- Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistanceThe Lancet, 2013
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) VirusNew England Journal of Medicine, 2013
- Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in MiceAntimicrobial Agents and Chemotherapy, 2008
- Mechanisms of action of ribavirin against distinct virusesReviews in Medical Virology, 2005
- The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagenNature Medicine, 2000